SCHEMBL19859922

SCHEMBL19859922

COC(=O)C(N)CC(=O)Nc1ccc2ccccc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
GAA P10253 1/20 0.66
SLC1A3 P43003 3/20 0.60
SLC1A2 P43004 3/20 0.60
SLC1A1 P43005 3/20 0.60
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
CYP1A2 P05177 2/20 0.57
KDM4E B2RXH2 2/20 0.57
CYP2C19 P33261 1/20 0.57
HIF1A Q16665 1/20 0.57
MAPT P10636 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
POLB P06746 1/20 0.56
NPC1 O15118 2/20 0.52
LMNA P02545 2/20 0.52
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19859923 0.85 SLC1A3 (0.80) RAB9ASMN1; SMN2GAASLC1A3SLC1A2
SCHEMBL19860037 0.84 NOTUM (0.55)
SCHEMBL31643225 0.80 RAB9A (1.00) RAB9ASMN1; SMN2GAASLC1A3SLC1A2
SCHEMBL14152982 0.80 SLC1A3 (0.66) RAB9ASMN1; SMN2SLC1A3SLC1A2SLC1A1
SCHEMBL14152969 0.80 SLC1A3 (0.66) RAB9ASMN1; SMN2SLC1A3SLC1A2SLC1A1
SCHEMBL5907650 0.79 RAB9A (0.80) RAB9ASMN1; SMN2GAASLC1A3SLC1A2
SCHEMBL31136099 0.77 RAB9A (0.78) RAB9ASMN1; SMN2GAASLC1A3SLC1A2
SCHEMBL1913977 0.75 ALDH1A1 (0.73) RAB9ASMN1; SMN2GAAALDH1A1MEN1
SCHEMBL1285643 0.75 ALDH1A1 (0.73) RAB9ASMN1; SMN2GAAALDH1A1MEN1
SCHEMBL31152634 0.75 ALDH1A1 (0.73) RAB9ASMN1; SMN2GAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890123-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2018-02-13 US disclosed